Emcure Pharmaceuticals Ltd
₹1942.20
as on
🔔 Block Trade Alert
Emcure Pharmaceuticals recorded an NSE block trade of Rs. 17.47 crore for approximately 90,289 shares at Rs. 1934.50 each.
What are INDmoney investors doing with Emcure Pharmaceuticals shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Search interest on INDmoney
-29%
Searches for Emcure Pharmaceuticals on INDmoney have decreased by 29% over the last 30 days.
Among the most traded stocks
405th
Emcure Pharmaceuticals was the 405th most traded stock on INDmoney over the last 7 days.
Average holding period of indmoney investors
23 days
INDmoney investors hold Emcure Pharmaceuticals shares for an average of 23 days.
Key Events for Emcure Pharmaceuticals
Emcure Pharmaceuticals Stock Performance
as on September 16, 2026 at 7:35 pm IST
Day's Low
Day's High
₹1,902.60₹2,013.00
2.04%
Downside
3.65%
Upside
52 Week's Low
52 Week's High
₹1,260.00₹2,048.0035.13%
Downside
5.45%
Upside
Emcure Pharmaceuticals share price movements today
- Previous Close
- ₹1,993.00
- Open
- ₹1,941.90
- Volume
- 1.95L
- Upper Circuit
- ₹2,192.30
- Lower Circuit
- ₹1,793.70
- Day's Low - High
- ₹1,902.60 - ₹2,013.00
- 52 Week Low - High
- ₹1,260.00 - ₹2,048.00
Emcure Pharmaceuticals Historical Returns
- 1 Month Return
- + 6.36 %
- 3 Month Return
- + 14.87 %
- 1 Year Return
- + 46.5 %
- 3 Year Return
- + 46.64 %
- 5 Year Return
- + 46.64 %
Emcure Pharmaceuticals Fundamentals
as on September 16, 2026 at 2:05 pm IST
Market Cap
₹37,809.33 Cr
Return on Equity (ROE)
21.77
PE Ratio (TTM)
37.09
Return on capital employed (ROCE)
22.83
Industry PE ratio
51.81
Beta (LTM)
0.5
P/B Ratio
8.15
Dividend Yield
0.23
PEG Ratio
2.63
Quarterly Earnings Growth YOY
36.17
EPS (TTM)
49.65
Book Value
261.09
Emcure Pharmaceuticals Stock Valuation
as on September 16, 2026 at 2:05 pm IST
Emcure Pharmaceuticals in the last 5 years
Lowest (24.97x)
April 9, 2025
Today (37.09x)
September 11, 2026
Industry (51.81x)
September 11, 2026
Highest (53.98x)
September 18, 2024
Today’s Price to Earnings Ratio: 37.09x
Emcure Pharmaceuticals Technical Analysis
Track how Emcure Pharmaceuticals technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 0.34 | |
CCI (20) | 510.45 | |
RSI (14) | 54.88 | Neutral |
Momentum (10) | 0.9 | Bullish |
ADI (14) | 27.85 | |
Ultimate Oscillator (7,14,28) | 35.58 | Neutral |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 1939.74 | Bullish |
EMA (20) | 1939.53 | Bullish |
VWMA (20) | 1939.84 | Bullish |
SMA (50) | 1938.55 | Bullish |
EMA (50) | 1938.91 | Bullish |
SMA (200) | 1936.24 | Bullish |
EMA (200) | 1939.43 | Bullish |
KAMA (200) | 1937.15 | Bullish |
DEMA (200) | 1932.51 | Bullish |
Emcure Pharmaceuticals Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Emcure Pharmaceuticals with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 37,809.33 | 9.33% | 0.63 | 941 | 9,203 | |
| BUY | 49,025.80 | 10.06% | 0.61 | 1,191 | 9,646 | |
| BUY | 38,676.99 | 35.83% | 0.50 | 709 | 4,147 | |
| HOLD | 95,570.89 | 3.22% | 0.59 | 4,157 | 33,700 | |
| BUY | 55,515.63 | 4.88% | 0.00 | 1,414 | 6,445 |
Market expectation of Emcure Pharmaceuticals Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
87.50%
Buy
12.50%
Hold
0.00%
Sell
Emcure Pharmaceuticals Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Emcure Pharmaceuticals Ltd Annual Profit & Loss
Figures in Rupees Crores
Emcure Pharmaceuticals Ltd Cash Flow
Figures in Rupees Crores
Mutual Funds Buying / Exiting Emcure Pharmaceuticals
Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures
Mutual Funds Buying Emcure Pharmaceuticals
Sorted by largest increase in holding, month-over-month.
Fund Name | Value of Holding | Increase (MoM) | Holding % |
|---|---|---|---|
 Kotak Mid Cap Fund Direct Growth | ₹838.06 Cr | ₹140.15 Cr (+20.08%) | 1.12% |
Mutual Funds Exiting Emcure Pharmaceuticals
Sorted by largest decrease in holding, month-over-month.
Fund Name | Value of Holding | Decrease (MoM) | Holding % |
|---|---|---|---|
 Nippon India Multi Cap Fund - Direct Plan - Growth | ₹316.53 Cr | ₹17.12 Cr (-5.13%) | 0.54% |
Emcure Pharmaceuticals Corporate Actions
View detailed summary of the earnings and dividend history of Emcure Pharmaceuticals.
Emcure Pharmaceuticals Ltd Earnings Results
Emcure Pharmaceuticals Ltd’s net profit jumped 42.05% since last year same period to ₹293.98Cr in the Q1 2026-2027. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated 20.78% jump in its net profits since last 3-months.
Read More about Earnings ResultsEmcure Pharmaceuticals Ltd Dividends May,2026
In the quarter ending March 2026, Emcure Pharmaceuticals Ltd has declared dividend of ₹3.60 per share on 05 May 2026 - translating a dividend yield of 0.18%.
Read More about Dividends
Indices Featuring Emcure Pharmaceuticals Stock
Check stock indices that include Emcure Pharmaceuticals.
Insights on Emcure Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 3.35% to 4.88% in Jun 2026 quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, EMCURE stock has moved up by 4.1%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 4.94% to 6.87% in Jun 2026 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 12.69% to 8.83% in Jun 2026 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 77.87% to 77.83% in Jun 2026 quarter
About Emcure Pharmaceuticals Ltd
Revenue: ₹2,580.45Cr as on June 2026 (Q1 FY27)
Net Profit: ₹292.49Cr as on June 2026 (Q1 FY27)
Listing date: 10 Jul, 2024
| Organisation | Emcure Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs
What is Emcure Pharmaceuticals share price today?
Emcure Pharmaceuticals share price today stands at ₹1942.2 as on . Emcure Pharmaceuticals share today touched a day high of ₹2013 and a low of ₹1902.6.
What is the 52 week high and 52 week low range for Emcure Pharmaceuticals share?
Emcure Pharmaceuticals touched a 52 week high of ₹2048 and a 52 week low of ₹1260. Emcure Pharmaceuticals share price today i.e. is trending at ₹1942.2, which is -5.17% down from its 52 week high and 54.14% up from its 52 week low.
What is Emcure Pharmaceuticals's market capitalisation today?
Emcure Pharmaceuticals market capitalisation is ₹37,809.33 Cr as on .
How to buy Emcure Pharmaceuticals shares?
To buy Emcure Pharmaceuticals shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for EMCURE or Emcure Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Emcure Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Emcure Pharmaceuticals trading volume today?
Emcure Pharmaceuticals trading volume is 1.95L as on . This means that 1.95L shares of Emcure Pharmaceuticals were bought and sold on the stock market during today's trading session.